Moreover, knockdown of HMGB1 or S1R, as well as overexpression of Sirt6, alleviates diabetic nephropathy by regulating the NRF2 pathway, indicating the potential of NRF2 as a research target [61, 128, 129]. Here, NFE2L2 is linked to diabetic kidney disease.